Apply manufacturing and supply chain principles to make informed decisions about production scale-up, CMO partnerships, and risk mitigation for a hypothetical biotech asset.
For a biotech manager, scaling up manufacturing for a drug candidate is a high-stakes challenge. As your monoclonal antibody progresses through clinical trials, you're not just preparing for bigger production numbers—you’re safeguarding the future of your company. The leap from producing 50 kg/year to 2,000 kg/year isn't merely an operational concern; it's a strategic imperative. Delays or missteps can result in missed market opportunities, potential revenue losses, and even jeopardize the drug's approval timeline. The pressure is on to ensure that your manufacturing strategy is robust, cost-efficient, and compliant with regulatory standards. Partnering with a Contract Manufacturing Organization (CMO) for…
Sign up free — one personalized lesson every day, matched to your role and goals.
Already have an account? Sign in